Pharma Foods International Co., Ltd. (2929.T)
JPY 934.0
(-0.43%)
JPY 934.0
(-0.43%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | 62.14 Billion | 68.57 Billion | 60.18 Billion | 46.75 Billion | 15.35 Billion | 10.53 Billion |
| Cost of Revenue | 13.39 Billion | 13.29 Billion | 12.07 Billion | 7.02 Billion | 3.17 Billion | 1.99 Billion |
| Gross Profit | 48.75 Billion | 55.27 Billion | 48.1 Billion | 39.72 Billion | 12.17 Billion | 8.53 Billion |
| Operating Expenses | 43.63 Billion | 51.66 Billion | 47.02 Billion | 34.04 Billion | 11.43 Billion | 7.96 Billion |
| Selling, General and Administrative Expenses | 42.56 Billion | 42.96 Billion | 39.16 Billion | 27.61 Billion | 8.35 Billion | 5.68 Billion |
| Research and Development Expenses | 978 Million | 840 Million | 766 Million | 522 Million | 437.68 Million | 317.16 Million |
| Other Expenses | 100 Million | 89 Million | 7.1 Billion | 5.91 Billion | 2.64 Billion | 1.96 Billion |
| Cost and Expenses | 57.03 Billion | 64.96 Billion | 59.1 Billion | 41.07 Billion | 14.61 Billion | 9.95 Billion |
| Operating Income | 5.11 Billion | 3.61 Billion | 1.08 Billion | 5.67 Billion | 740.01 Million | 576.25 Million |
| Interest Expense | 62 Million | 48 Million | 26 Million | 12 Million | 8.48 Million | 7.35 Million |
| Income Tax Expense | 1.82 Billion | 462 Million | 1.79 Billion | 1.92 Billion | 157.7 Million | 160.76 Million |
| Earnings before Tax | 5.03 Billion | 3.54 Billion | 1.42 Billion | 5.76 Billion | 848.65 Million | 668.57 Million |
| Net Income | 3.2 Billion | 3.08 Billion | -374 Million | 3.84 Billion | 690 Million | 499.84 Million |
| Earnings Per Share Basic | 112.69 | 106.70 | -12.89 | 132.21 | 23.79 | 17.21 |
| Earnings Per Share Diluted | 112.69 | 106.70 | -12.89 | 132.14 | 23.78 | 17.21 |
| Weighted Average Shares Outstanding | 28.44 Million | 28.87 Million | 29.01 Million | 29.05 Million | 29.03 Million | 29.03 Million |
| Weighted Average Shares Outstanding (Diluted) | 28.44 Million | 28.87 Million | 29.01 Million | 29.06 Million | 29.05 Million | 29.04 Million |
| Gross Margin | 0.78 | 0.81 | 0.80 | 0.85 | 0.79 | 0.81 |
| EBIT Margin | 0.10 | 0.06 | 0.03 | 0.13 | 0.06 | 0.07 |
| Profit Margin | 0.05 | 0.04 | -0.01 | 0.08 | 0.04 | 0.05 |
| EBITDA | 6.02 Billion | 4.15 Billion | 1.6 Billion | 5.85 Billion | 1 Billion | 767.46 Million |
| Earnings Before Tax Margin | 0.08 | 0.05 | 0.02 | 0.12 | 0.05 | 0.05 |
| Breakdown | 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY |
|---|---|---|---|---|---|---|
| Revenue | 14.97 Billion | 15.51 Billion | 15.51 Billion | 16.14 Billion | 16.03 Billion | 68.57 Billion |
| Cost of Revenue | 3.52 Billion | 3.33 Billion | 3.16 Billion | 3.42 Billion | 3.06 Billion | 13.29 Billion |
| Gross Profit | 11.45 Billion | 12.18 Billion | 12.34 Billion | 12.71 Billion | 12.97 Billion | 55.27 Billion |
| Operating Expenses | 9.6 Billion | 10.45 Billion | 11.4 Billion | 12.11 Billion | 10.99 Billion | 51.66 Billion |
| Selling, General and Administrative Expenses | 7.42 Billion | 10.22 Billion | 11.2 Billion | 9.93 Billion | 8.77 Billion | - |
| Research and Development Expenses | 273 Million | 223 Million | 205 Million | 277 Million | 241 Million | - |
| Other Expenses | 1.9 Billion | -11 Million | 6 Million | 13 Million | 41 Million | 89 Million |
| Cost and Expenses | 13.12 Billion | 13.78 Billion | 14.57 Billion | 15.53 Billion | 14.06 Billion | 64.96 Billion |
| Operating Income | 1.84 Billion | 1.73 Billion | 934 Million | 601 Million | 1.97 Billion | 3.61 Billion |
| Interest Expense | 18 Million | 17 Million | 13 Million | 14 Million | 11 Million | 48 Million |
| Income Tax Expense | 451 Million | 603 Million | 456 Million | 318 Million | -54 Million | 462 Million |
| Earnings before Tax | 1.8 Billion | 1.69 Billion | 937 Million | 605 Million | 1.95 Billion | 3.54 Billion |
| Net Income | 1.34 Billion | 1.08 Billion | 482 Million | 286 Million | 2.01 Billion | 3.08 Billion |
| Earnings Per Share Basic | 48.06 | 38.76 | 16.75 | 9.92 | 69.79 | - |
| Earnings Per Share Diluted | 48.06 | 38.76 | 16.75 | 9.92 | 69.79 | - |
| Weighted Average Shares Outstanding | 28.06 Million | 28.07 Million | 28.77 Million | 28.84 Million | 28.84 Million | 28.87 Million |
| Weighted Average Shares Outstanding (Diluted) | 28.06 Million | 28.07 Million | 28.77 Million | 28.84 Million | 28.84 Million | 28.87 Million |
| Gross Margin | 0.76 | 0.79 | 0.80 | 0.79 | 0.81 | 0.81 |
| EBIT Margin | 0.12 | 0.12 | 0.07 | 0.04 | 0.13 | - |
| Profit Margin | 0.09 | 0.07 | 0.03 | 0.02 | 0.13 | 0.04 |
| EBITDA | 1.83 Billion | 1.88 Billion | 1.1 Billion | 644 Million | 2.04 Billion | - |
| Earnings Before Tax Margin | 0.12 | 0.11 | 0.06 | 0.04 | 0.12 | 0.05 |
FOF
600517
4549
BBSS
CARA
BME